Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Aaron Logan MD, PhD

Aaron C. Logan MD, PhD

Associate Professor, Hematology, BMT, & Cellular Therapy, University of California, San Francisco, California

Dr. Aaron Logan is an Associate Professor of Clinical Medicine at the University of California, San Francisco (UCSF) in the Division of Hematology, Blood and Marrow Transplantation, and Cellular Therapy. His clinical practice focuses on the management of patients with acute leukemias, myelodysplastic syndrome, aplastic anemia and hemophagocytic lymphohistiocytosis. Dr. Logan is a specialist in non-transplant, transplant, and cellular therapies. Dr. Logan also runs a research laboratory and is Director of the Hematologic Malignancies Tissue Bank at UCSF. His research interests focus on the application of next generation sequencing of immunoreceptor genes to quantify measurable residual disease (aka, minimal residual disease) in acute lymphoblastic leukemia, quantify B and T cell immune reconstitution after allogeneic hematopoietic cell transplantation, and to quantify and track malignancy-, pathogen-, and autoantigen-targeted immune responses following transplantation or immunotherapy.

Disclosures

Research Funding: Amgen, Astellas, Autolus, Jazz, Kadmon, Kite, Pharmacyclics

Consulting: Abbvie, Bristol-Myers Squibb, Pfizer